UBS China International Capital (3908.HK) M&A Analyst Briefing Takeaways
Summaries are public. PDF access requires an active membership; all members have the same access. Sign in
UBS hosted an analyst briefing on China International Capital Corporation, ticker 3908.HK, focusing on its mergers and acquisitions franchise. CICC maintained a leading position in the domestic M&A market during 2025, with transaction value growing 15% year-over-year and capturing roughly 12% market share.
Management highlighted cross-border M&A and state-owned enterprise restructuring as the primary growth drivers, projecting a 10% to 15% increase in M&A revenue for 2026. The current M&A pipeline stands at a historic high, though deal execution cycles may lengthen due to ongoing regulatory and market complexities.
CICC has demonstrated particularly strong advisory capabilities in the technology, healthcare, and energy sectors. The firm completed multiple transactions exceeding $1 billion in 2025, including a notable cross-border SOE acquisition. M&A business margins remain above 30%, exceeding the industry average.
Management anticipates a stabilizing regulatory environment, which should facilitate the execution of large transactions. To capture emerging cross-border opportunities, CICC plans to expand its teams across Southeast Asia and Europe. The bank competes directly with Goldman Sachs and Morgan Stanley for mandates on large deals. Management did not provide specific price targets or ratings.
Key exhibits
Exhibit 1
Exhibit 2
